Paperpal Prime Logo

International Journal of Hematology : Impact Factor & More

eISSN: 1865-3774pISSN: 0925-5710

Aims and Scope of International Journal of Hematology

International Journal of Hematology is the official journal of the Japanese Society of Hematology. Since 2008, it has been published by Springer Japan, but used to be published by Carden Jennings.

Key Metrics

CiteScore
3.9
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Journal of Hematology

International Journal of Hematology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER JAPAN KK
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Journal of Hematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Journal of Hematology

Clinical implications of minimal residual disease monitoring in multiple myeloma.
  • 1 Jul 2026
  • International journal of hematology
Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.
  • 1 Jul 2026
  • International journal of hematology
Recent advances in the pathophysiology and treatment of plasma cell dyscrasias.
  • 1 Jul 2026
  • International journal of hematology
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.
  • 1 Jul 2026
  • International journal of hematology
Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction.
  • 1 Jul 2026
  • International journal of hematology
Clinical implications of minimal residual disease monitoring in multiple myeloma.
  • 1 Jul 2026
  • International journal of hematology
Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.
  • 1 Jul 2026
  • International journal of hematology
Recent advances in the pathophysiology and treatment of plasma cell dyscrasias.
  • 1 Jul 2026
  • International journal of hematology
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.
  • 1 Jul 2026
  • International journal of hematology
Rapid regression of a bulky cranial lesion in high-risk multiple myeloma with isatuximab-based quadruplet induction.
  • 1 Jul 2026
  • International journal of hematology

FAQs on International Journal of Hematology